MYC and cancer: Mahapatra et al. developed a HTS technique to discover molecules like 6896009, which selectively curtails cancer cell proliferation by disrupting the interaction between IGF2BP1 and c-Myc mRNA, a critical regulator of this oncogene expression [66].